Evidence map›Paper›PMID 38787060›Full record

ArticleToxins2024

Specificity of DNA ADP-Ribosylation Reversal by NADARs.

Bara Cihlova, Yang Lu, Andreja Mikoč, Marion Schuller, Ivan Ahel

Abstract read
In one paragraph

Article in Toxins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bara CihlovaSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.ORCID 0009-0000-0613-6804
Yang LuSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
Andreja MikočDivision of Molecular Biology, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Marion SchullerSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.ORCID 0000-0002-1551-0359
Ivan AhelSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.ORCID 0000-0002-9446-3756

Funding

Biotechnology and Biological Sciences Research Council BB/R007195/1 and BB/W016613/1Cancer Research UK 22284Cancer Research UK C35050/A22284Ovarian Cancer Research Alliance 813369Oxford University Challenge Seed Fund USCF 456Wellcome TrustWellcome Trust 210634 and 223107
6 · The paper itself

Abstract

Recent discoveries establish DNA and RNA as bona fide substrates for ADP-ribosylation. NADAR ("NAD- and ADP-ribose"-associated) enzymes reverse guanine ADP-ribosylation and serve as antitoxins in the DarT-NADAR operon. Although NADARs are widespread across prokaryotes, eukaryotes, and viruses, their specificity and broader physiological roles remain poorly understood. Using phylogenetic and biochemical analyses, we further explore de-ADP-ribosylation activity and antitoxin functions of NADAR domains. We demonstrate that different subfamilies of NADAR proteins from representative

Indexed as

ADP-RibosylationEscherichia coliAdenosine Diphosphate RiboseBacterial ToxinsDNADNA, BacterialEscherichia coli ProteinsPhylogenyToxin-Antitoxin SystemsAdenosine Diphosphate RiboseBacterial ToxinsDNADNA, BacterialEscherichia coli ProteinsADP-ribosylationDarTGDNA damageDNA modificationPARPtoxin–antitoxin systemYbiA

Identifiers

PMID38787060
PMCPMC11125620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.